• banner
  • banner
  • banner

"Zitholele i-Cutting-Edge CAR T-Cell therapy, ukwelashwa kwe-TIL, ukwelashwa kwe-Stem cell kanye nezivivinyo zomtholampilo eziyisisekelo zokwelashwa komdlavuza okusha."

"Ngezixazululo ezintsha kanye nokuzinikela okungantengantengi, silwela ukuqeda izithiyo, sinikeze ithemba, futhi sibe neqhaza emhlabeni lapho umdlavuza ungelapheki nje kodwa unganqotshwa".

Ukwelashwa kwe-CAR T-Cell, izivivinyo zomtholampilo kanye nokwelashwa phesheya

Ikepisi lesithombe sekhadi

Ukwelashwa Kwamaseli

I-CancerFax iyinkundla yokuphayona ezinikele ekuxhumaniseni abantu ababhekene nomdlavuza wesigaba sekwephuzile ngemithi yokwelapha yamaseli efana Ukwelashwa kwe-CAR T-Cell, Ukwelashwa kwe-TIL, Ukwelashwa kweselula nezivivinyo zemitholampilo emhlabeni wonke. Ngokusebenzisa ubuchwepheshe obusezingeni eliphezulu kanye nenethiwekhi yomhlaba wonke yezikhungo zezokwelapha. Le sevisi esindisa ukuphila inika iziguli amandla okuhlola imingcele emisha ekwelapheni umdlavuza kuyilapho izinikeza ulwazi oluphelele mayelana nemibandela yokufaneleka yokuhlolwa, izindawo, nezinqubo zokubhalisa.

Ikepisi lesithombe sekhadi

Ukwelashwa Kwamanye Amazwe

ICancerFax ingumsizi wesiguli othenjwa kakhulu emhlabeni wonke, esebenza nezibhedlela eziphezulu zomdlavuza emhlabeni wonke njengo-MD Anderson, Dana Farber, Mayo Clinic, Parkway Singapore, Asan, Sheba, NCC Japan, Beijing Cancer Institute, Apollo, kanye neBLK Max ukukulethela Izidakamizwa nemithi yokwelapha engcono kakhulu neyakamuva. Ithimba lethu liqinisekisa ukuthi iziguli zithola izinsiza ezijwayelekile zokwelashwa komdlavuza phesheya e-USA, Japan, South Korea, Israel, China, and India.

 

Hlola imininingwane ukwelashwa komdlavuza phesheya.

Ikepisi lesithombe sekhadi

Izivivinyo zemitholampilo

Inkampani yethu igxile kakhulu ukuhlolwa komtholampilo komdlavuza amasevisi, ukusiza ukufinyelela ocwaningweni oluyisisekelo kanye nezinketho zokwelapha. Sixhuma iziguli nezivivinyo ezisezingeni eliphezulu, ezikhuthaza ithemba kanye nenqubekelaphambili ekulweni nomdlavuza. Ngokuzibophezela ekwenzeni ngcono izimpilo, sihamba phambili ekuthuthukiseni ukunakekelwa komdlavuza ngokusungula izindlela ezintsha zomtholampilo.

 

Hlola imininingwane ukuhlolwa kwemitholampilo yomdlavuza.

"Ngibonga kakhulu ngokwesekwa nesiqondiso engasithola lapho ngivakashele e-USA ukuze ngiyohlolwa umdlavuza. Ithimba elenza lo mzamo libonise ukuzibophezela okungaguquki enhlalakahleni yami kanye nokuqonda okujulile ngobunkimbinkimbi bocwaningo lwezokwelapha. Ubungcweti babo kanye nokuqonda kwabo okujulile kocwaningo lwezokwelapha. ukuzinikela akunginikanga nje kuphela ukufinyelela ekwelashweni okuphambili kodwa kuphinde kwafaka ithemba nethemba ngesikhathi esiyinselele. Ngempela, ithimba elimangalisayo elenza umehluko!"

Allam Lim
I-Leukemia Cancer Survivor, ePhilippines

Izivivinyo zemitholampilo

ICancerFax igxile kakhulu ekuqondiseni abantu ngenqubo eyinkimbinkimbi yokubhalisa ezivivinyweni zomtholampilo zomdlavuza. Ngokuzinikezela okungantengantengi, sixhuma iziguli ocwaningweni olusezingeni eliphezulu kanye nezinketho zokwelapha, sinikeza umzila wethemba empini yazo yokulwa nomdlavuza.

Ithimba lethu lochwepheshe abanozwelo lizulazula emhlabeni oyinkimbinkimbi wezivivinyo zomtholampilo, liqinisekisa ukuthi sonke isiguli sithola ukwesekwa komuntu siqu nesiqondiso. Sizibophezele ekunikezeni amandla iziguli, ukuzinikeza ukufinyelela ekwelapheni okusha, kanye nokuqhubekisela phambili impi yokulwa nomdlavuza. Enkampanini yethu, sikholwa ukuthi ukuhlanganyela ezivivinyweni zomtholampilo kungaba isinyathelo esibalulekile esiya ekusasa eliqhakazile.

 

Hlola imininingwane ukuhlolwa kwemitholampilo yomdlavuza.

I-CAR T-Cell Therapy

Ukwelashwa kwe-CAR T Cell kuyindlela yokuguqula i-immunotherapy enikeza ithemba elisha ekulweni nomdlavuza. I-CAR, emele i-Chimeric Antigen Receptor, iyisamukeli sokwenziwa esakhelwe ama-T cell esiguli, isivikelo esingokwemvelo somzimba ezifweni. Lawa maseli e-CAR T ashintshiwe aklanyelwe ukubona futhi ahlasele amangqamuzana omdlavuza athile ngokunemba, konga izicubu ezinempilo. Ukwelashwa kwe-CAR T cell kubonise impumelelo ephawulekayo, ikakhulukazi ekwelapheni izinhlobo ezithile ze-leukemia ne-lymphoma, okuholela ekukhululweni nasekuthuthukisweni kwamazinga okusinda kwezinye izimo.

Naphezu kwezinselele ezifana nemiphumela engemihle engase ibe khona kanye nezindleko eziphakeme, ucwaningo oluqhubekayo luhlose ukwandisa ukusetshenziswa kwalo ezinhlobonhlobo zomdlavuza, okuthembisa ikusasa eliqhakazile empini yokulwa nalesi sifo esesabekayo.

 

Hlola imininingwane Ukwelashwa kwe-CAR T-Cell.

"Ukwelashwa kwe-CAR T cell kwakuyiyona ndlela yokuphila kwami. Ngemva kweminyaka yokulwa nomdlavuza, lokhu kwelashwa kwaletha ushintsho oluyisimangaliso. Kwaba sengathi amangqamuzana ami aba amaqhawe omdlavuza angesabi. Namuhla, ngiwubufakazi obuphilayo bokuthi isayensi nethemba kunganqoba ngisho nezimpi ezinzima kakhulu. . Ngiyabonga, i-CAR T cell therapy."

Daljeet Singh
I-Non-Hodgkin Lymphoma Survivor, eNdiya

"Ngibonga kakhulu ngokwelashwa okukhethekile komdlavuza wamaphaphu engakuthola e-USA. Ithimba lezokwelapha elizinikele, izikhungo zesimanjemanje, kanye nemithi emisha yanginika ithemba kanye nethuba lesibili lokuphila. Ukunakekelwa kwabo kozwelo nobuchule benziwe benza wonke umehluko ohambweni lwami lokululama."

Nowak Kowalska
Owasinda kumdlavuza wamaphaphu, e-Polland

Ukwelashwa komdlavuza e-USA

E-USA, ukunakekelwa komdlavuza osezingeni eliphezulu kuwukuhlanganiswa okumangalisayo kokuqanjwa kabusha, ucwaningo, nokunakekelwa okuhlanganisa konke. Izibhedlela eziphezulu zomdlavuza e-USA sebenzisa ubuchwepheshe obusezingeni eliphezulu njenge-immunotherapy kanye nemithi enembile ukwenza izindlela zokwelapha ngokwezifiso zofuzo lwesiguli ngasinye kanye nohlobo lomdlavuza. Leli su elenzelwe wena likhiqize imiphumela engcono kanye nemiphumela engemihle embalwa. Izivivinyo zemitholampilo nazo zifinyeleleka kalula, okunikeza iziguli ukufinyelela ekwelashweni okusha okubonisa isithembiso sesikhathi esizayo. Kodwa-ke, izindleko eziphezulu zokwelashwa komdlavuza zisaqhubeka nokuba yinkinga, okubangela izingxoxo eziqhubekayo mayelana nokufinyelela kanye nokufinyeleleka kokunakekelwa kwezempilo.

Iziguli ezinomdlavuza kanye nemindeni yazo zisaqhubeka nokuba nethemba ngenxa yokuzinikela kwe-USA ekwelapheni umdlavuza.

 

Hlola imininingwane ukwelashwa komdlavuza e-USA.

Ukwelapha umdlavuza eNdiya

Ukwelashwa komdlavuza e-India kwenze intuthuko enkulu, kuhlinzeka ngemithi yokwelapha ethuthukisiwe njengokuhlinzwa, i-chemotherapy, imisebe, kanye ne-immunotherapy. Izibhedlela eziphezulu zomdlavuza eNdiya njenge-Tata Memorial Centre, i-Apollo Cancer Hospital, i-BLK, i-Artemis, i-Asian Oncology, i-American Oncology, i-HCG, njll., inikeza ukunakekelwa okusezingeni lomhlaba.

Inzuzo ye-India isekuthengeni, ukuheha abavakashi bezokwelapha abafuna ukwelashwa komdlavuza kwekhwalithi ephezulu, nengabizi.

 

Hlola imininingwane ukwelashwa komdlavuza eNdiya.

“Ngavakashela e-India ukuze ngiyolashelwa umdlavuza webele. Ngiqede ukuhlinzwa kwami, ukwelashwa ngamakhemikhali kanye nokwelashwa ngemisebe ngama-$8500 USD kuphela. Manje anginawo umdlavuza. Ngingasho ukuthi i-India inokwelashwa komdlavuza okungcono kakhulu futhi ukonga kakhulu."

Amanda Ncube
I-Breast Cancer Survivor, eZimbabwe

"Angikwazi ukubonga i-Parkway Cancer Centre ngokwanele ngokungeseka kwabo okungantengantengi kanye nokunakekelwa okukhethekile ngesikhathi ngilwa nomdlavuza wesibindi. Ithimba lonke, kusukela kodokotela be-oncologists kuya kwabahlengikazi, bangiphatha ngozwela nangobuchwepheshe. Ukwelashwa kwabo okunqamulelayo kanye nendlela yabo yomuntu siqu yadlala indima enkulu. indima ebalulekile ekululameni kwami ​​ngempumelelo."

Mohammad Nazakat Khan
Owasinda kumdlavuza wesibindi, ePakistan

Ukwelashwa komdlavuza eSingapore

Ukwelashwa komdlavuza eSingapore kubonakala ngobuchwepheshe bezokwelapha obusezingeni eliphezulu kanye nendlela ephelele yokunakekela. Izikhungo ezisezingeni lomhlaba njengeParkway Cancer Center zihlinzeka ngohlu olubanzi lwezindlela zokwelapha, kusukela ekuhlinzweni nasekwelapheni ngamakhemikhali kuya ekwelapheni okuhlosiwe kanye ne-immunotherapy. Amaqembu ahlukahlukene ongoti be-oncologists abanolwazi benza izinhlelo zokwelashwa eziqondene nomuntu, ziqinisekisa imiphumela engcono kakhulu yeziguli. Uhlelo lwezempilo lwaseSingapore lwaziwa ngokusebenza kahle kwalo nokufinyeleleka, luheha iziguli emhlabeni wonke.

Ngaphandle kokunakekelwa kwezempilo, izwe lihlinzeka ngendawo esekela iziguli nemindeni yazo, ngamaqembu amaningi okusekela kanye nezinsizakalo zokwelulekwa ukusiza ukuzulazula ohambweni oluyinselele lokwelashwa komdlavuza.

 

Hlola imininingwane ukwelashwa komdlavuza eSingapore.

Ukwelashwa komdlavuza eSouth-Korea

Ukwelashwa komdlavuza eSouth Korea kubonakala ngenhlanganisela evumelanayo yezindlela zendabuko nesimanje ekunakekelweni kwezempilo. Izikhungo zezokwelapha ezihamba phambili njengeNational Cancer Center Korea kanye ne-Asan Medical Center zinikeza ubuchwepheshe besimanje kanye nendlela ephelele yokugxilisa isiguli. Uhlelo lokunakekelwa kwezempilo lwaseNingizimu Korea ludume ngokusebenza kahle kwalo, ukufinyeleleka, kanye nekhwalithi yokunakekelwa, luheha iziguli emhlabeni wonke.

Izwe linomkhakha wezokuvakasha wezokwelapha ophumelelayo, ohlinzeka ngemithi ethuthukisiwe njengomuthi onembile kanye nokwelashwa kwamasosha omzimba. Iziguli azizuzi nje kuphela ekwelashweni kwesimanjemanje kodwa futhi kusukela ohlelweni olusekelayo lwe-ecosystem yocwaningo, izivivinyo zemitholampilo, kanye nezinsizakalo ezibanzi zokunakekelwa komdlavuza.

 

Hlola imininingwane ukwelashwa komdlavuza eNingizimu-Korea.

"Amazwi awakwazi ukubonga i-Asan Medical Center ngokunginakekela okukhethekile ngesikhathi ngilwa nomdlavuza wegazi. Ithimba labo elinamakhono odokotela begazi kanye nabahlengikazi bahlanganisa ubuchwepheshe nokusekela okungantengantengi, bangihola ohambweni oluyinselele. Ukuzibophezela kuka-Asan ekwelashweni okusezingeni eliphezulu, okuhlanganisa ukufakelwa kwe-stem cell, bekubalulekile ekululameni kwami ​​okuyimpumelelo. Ngaphandle kokuphumelela kwezokwelapha, uzwela lwabo lwangempela nokunakekela komuntu siqu kwenza umehluko. Ngingumsizi oziqhenyayo namuhla ngenxa yokuzinikela kwe-Asan Medical Center ekuqedeni umdlavuza wegazi."

Mohsin Ibrahimi
Owasinda kumdlavuza wegazi, e-Iran

"Njengomuntu osinde kumdlavuza wamaphaphu, ngikweleta ithuba lami lesibili lokuphila ngenxa yokunakekelwa kwenu okukhethekile kanye nobuchule benu. Ithimba lenu elizinikele lodokotela be-oncologist nabahlengikazi babonise ukungeseka okungenakunyakaziswa kulo lonke uhambo lwami. Ukuzinikela kukaSheba ocwaningweni nasekusunguleni izinto kukhanya ngokugqamile, kunikeza ithemba ezigulini ezinjengami. . Ngiyabonga ngokungibuyisela impilo yami."

Albert Steve
Owasinda kumdlavuza wamaphaphu, eNigeria

Ukwelashwa komdlavuza kwa-Israyeli

Ukwelashwa komdlavuza kwa-Israyeli kumi phambili emisha yezokwelapha. Idume ngocwaningo lwayo oluthuthukisiwe kanye nemithi yokuphayona, uhlelo lwezempilo lwakwa-Israel lunikeza ukunakekelwa kwe-oncology okusezingeni lomhlaba. Izikhungo ezihamba phambili ezifana neSheba Medical Center kanye neSibhedlela saseHadassah zisebenzisa ubuchwepheshe besimanjemanje, umuthi oqondile, kanye nokwelashwa kwamasosha omzimba ukuze kuliwe nomdlavuza ngempumelelo.

Indawo yokusebenzisana yakwa-Israel ikhuthaza ucwaningo oluyisisekelo kanye nezivivinyo zomtholampilo, ikwenze kube isizinda sokuqanjwa kabusha kwe-oncology. Ukwengeza, indlela yozwela nemikhakha eminingi iqinisekisa ukunakekelwa kwesiguli okuphelele, kuyilapho abavakashi bezokwelapha befuna ubuchwepheshe bayo. Ukuzibophezela kuka-Israyeli ekwelashweni komdlavuza kudlulela ngale kwemingcele, kunikeza ithemba nezixazululo ezithuthukile ezigulini emhlabeni wonke.

Ukwelashwa kwe-CAR T-Cell eNdiya

I-CAR-T cell therapy yaseNdiya, i-NexCAR19, iyisu lokuqala lezwe lendabuko lokulwa nomdlavuza. Idalwe yi-ImmunoACT, igatsha le-IIT Bombay, lokhu kwelashwa okuthuthukisiwe kusebenzisa ama-T-cell ashintshwe izakhi ukuze aqondise futhi aqede amangqamuzana anomdlavuza, ikakhulukazi emazingeni egazi afana ne-leukemia kanye ne-lymphomas. Izivivinyo zokuqala zibonisa amandla, cishe amaphesenti angama-50 athola ukuxolelwa okuphelele, ikakhulukazi ezimweni zentsha ze-B-cell acute lymphoblastic leukemia.

 

I-NexCAR19 ibonisa ukuncipha kwe-neurotoxicity uma kuqhathaniswa nezinketho zangaphandle, okubonisa izinzuzo ezingaba khona phezu kokwelashwa kwamanje. I-India ihlela ukunikeza lokhu kwelashwa ngezindleko ezincishisiwe uma kuqhathaniswa nezintengo zomhlaba wonke, kusukela ku-INR 30–40 lakhs futhi ihlose ukuyehlisa ibe ngama-INR 10–20 lakhs ngemvume engokomthetho.

 

Bheka imininingwane ku Ukwelashwa kwe-CAR T-Cell eNdiya.

"Kule minyaka emine edlule, sithole ubuchwepheshe obuyingqayizivele ekufinyeleleni isimo sezempilo sesiguli kanye nokukhetha ukwelashwa okufanele kanye nokuhlolwa komtholampilo."

U-Huang Lin
Umphathi Wokunakekela Iziguli, CancerFax - China

“Ngibhala lobu bufakazi ukuze ngidlulise ukubonga kwami ​​okukhulu ngokushintsha impilo engibe nakho ngokwelashwa kwe-CAR T-cell eChina. Uhambo lwami lokulwa nomdlavuza lwashintsha ngendlela enethemba lapho ngingeniswa kulokhu kwelashwa okuyisisekelo, futhi bekuyinto emangalisayo. Ngaphambi kokwelashwa kwe-CAR T-cell, ngase ngikhathele ukwelashwa okuvamile ngaphandle kwempumelelo enkulu. Isimo sami sasinzima, nethemba lase lifiphala. Nokho, isinqumo sami sokwelashwa nge-CAR T-cell eShayina saba inguquko. Izinga lokunakekelwa nobungcweti engaluthola lalingavamile. Ithimba lezokwelapha lalingenalo ikhono eliphezulu kuphela kodwa futhi lalinobubele ngendlela emangalisayo, linginikeza ukwesekwa nokuqinisekiswa engangikudinga phakathi nalesi sikhathi esinzima. ”

Bjorn Simenson
I-Multiple Myeloma Survivor, eNorway

Ukwelashwa kwe-CAR T-Cell eChina

Ukwelashwa kwe-CAR T-cell eChina ibone intuthuko emangalisayo eminyakeni yamuva nje, ikhombisa inqubekelaphambili yomhlaba wonke kulokhu kwelashwa komdlavuza osezingeni eliphezulu. Njengoba kunezilingo zomtholampilo eziqhubekayo ezingaphezu kuka-700, i-China ihola ukuthuthukiswa kokwelashwa kwe-CAR T-Cell. I-China iye yakwamukela ngokushesha ukwelashwa kwe-CAR T-cell, okunikeza ithemba elisha ezigulini ezilwa nomdlavuza ohlukahlukene, okuhlanganisa i-leukemia ne-lymphoma. Izibhedlela eziningana zaseShayina nezikhungo zocwaningo ziqhuba izivivinyo zemitholampilo ngenkuthalo futhi zihlinzeka ngokwelashwa kwe-CAR T-cell ezigulini ezifanele.

Ingqalasizinda eqinile yezwe kanye nokufinyelela kubantu abaningi abaneziguli kusheshise imizamo yocwaningo nentuthuko. Ngokuzibophezela ekuthuthukiseni lolu hlelo olusha lokwelapha, i-China ibamba iqhaza elikhulu endaweni yomhlaba wonke ye-immunotherapy yomdlavuza, ithuthukisa izindlela zokwelapha iziguli ezweni lonke.

 

Hlola imininingwane Ukwelashwa kwe-CAR T-Cell eChina.

Ukwelashwa kwe-CAR T-Cell kwa-Israyeli

Kwa-Israel, ukwelashwa kwe-CAR T-cell kuye kwavela njengendlela yokuguqula ekulweni nomdlavuza. Umkhakha wezokunakekelwa kwempilo wezwe, owaziwa ngocwaningo lwayo olusezingeni lomhlaba kanye nokusungula izinto ezintsha, wenze intuthuko enkulu ekuthuthukiseni nasekusebenziseni izindlela zokwelapha ze-CAR T-cell ezigulini ezinezifo ze-hematological kanye nezimila eziqinile.

Izikhungo zezokwelapha ezihamba phambili nezinkampani ze-biotechnology kwa-Israel zibambe iqhaza ngenkuthalo ezivivinyweni zemitholampilo namaphrojekthi ocwaningo, zicindezela imingcele yokwelashwa kwe-CAR T-cell. Imvelo yokusebenzisana yakwa-Israyeli kanye nobuchwepheshe obuphambili buyibeke njengesidlali somhlaba wonke ekuthuthukiseni i-immunotherapy, ihlinzeka ngezindlela ezintsha zokwelapha nethemba ezigulini ezinomdlavuza, ekhaya nasemhlabeni jikelele.

 

Hlola imininingwane Ukwelashwa kwe-CAR T-Cell kwa-Israyeli.

Lapho ngifika eSheba, ngabona ukuthi ngifike endaweni efanele. Yonke imibhalo yacutshungulwa phakathi nezinsuku eziyishumi, futhi yonke inqubo yayishesha futhi ilula. Udokotela wami kwakunguProf. Nagler, futhi uProf. Avraham Avigdor wahamba naye. Ngaba nombono omuhle ngabo; yonke into yayicacile futhi izolile. Njengami, umxhumanisi wami, uVika, naye ungowaseKyiv, ngakho sakha ubuhlobo ngokushesha. Abahlengikazi nabasebenzi bezokwelapha bahle kakhulu. Ifudumele kakhulu futhi inobungane. Okubaluleke kakhulu ukuthi inqubo ngokwayo ihambe kahle, ngaphandle kwezinkinga.”

Marina Oksana
I-Non-Hodgkin Lymphoma Survivor - Ukraine

“Ngifuna ukudlulisa ukwazisa kwami ​​okusuka enhliziyweni kochwepheshe bezokwelapha abazinikele nabacwaningi baseSingapore abayiphayona lendlela yokwelapha yezinguquko. Kunoma ubani ocabangela ukwelashwa kwe-CAR T-cell, ngikukhuthaza ngenhliziyo yonke ukuthi uhlole le nketho. Kube wuhambo olushintsha impilo kimi, futhi ngethemba ukuthi lungaletha ithemba elifanayo nokuphulukiswa kwabanye.”

UMitchell Kerp
I-Lymphoma Survivor, eNew Zealand

I-CAR T-Cell therapy eSingapore

Ukwelashwa kwe-CAR T-cell kungenelele kakhulu endaweni yokunakekelwa kwezempilo yase-Singapore, kunikeze indlela ethembisayo yokwelashwa komdlavuza. Ingqalasizinda yezokwelashwa esezingeni eliphezulu kanye namakhono ocwaningo yenze ukuthi kuthuthukiswe kanye nokusetshenziswa kwalokhu kwelashwa kokuzivikela komzimba okuphambili.

Iziguli eSingapore manje sezinokufinyelela ekwelashweni kwe-CAR T-cell komdlavuza wegazi ohlukahlukene, okumaka ushintsho oluguquguqukayo ekunakekelweni kwe-oncology. Izikhungo zokunakekelwa kwezempilo zasendaweni zibambe iqhaza ekuhlolweni kwemitholampilo kanye nokusebenzisana nochwepheshe bomhlaba wonke, ukuqinisekisa ukuthi iziguli zithola ukwelashwa okusezingeni lomhlaba. Ngokuzibophezela kwayo ekusungulweni nasekunakekeleni isiguli, iSingapore idlala indima ebalulekile ekuthuthukiseni ukwelashwa kwe-CAR T-cell, okuhlinzeka ngethemba elisha ezigulini ezinomdlavuza esifundeni nangale kwayo.

Hlola imininingwane I-CAR T-Cell therapy eSingapore.

Ukwelashwa kwe-FUCASO kwe-myeloma eminingi

I-China's National Medical Products Administration (NMPA) isanda kugunyaza i-BCMA entsha I-CAR T cell therapy yomdlavuza eChina ebizwa nge-FUCASO, okuphawula inguquko engaba khona ekulweni nalesi sifo esiyinkimbinkimbi. Ngakho-ke, yini i-myeloma eminingi, futhi kungani i-FUCASO idala isasasa elingaka?

Ucwaningo lwakamuva lubonisa isithembiso esimangalisayo phakathi novivinyo, ngezinga lokuphendula lilonke lama-96% kanye nezinga lokuphendula eliphelele lama-74.3% elibonwe ezigulini ezibhalisiwe eziyi-103. Le bhulogi ingena ijula ​​kwisayensi engemuva kwe-FUCASO, umthelela wayo ongaba khona ezigulini ze-myeloma, kanye nethemba elilethayo empini yomhlaba wonke yokulwa nalesi sifo esiyinselele.

Funda kabanzi mayelana Ukwelashwa kwe-FUCASO kwe-myeloma eminingi e-China.

 

Ucwaningo lwakamuva lubonisa isithembiso esimangalisayo phakathi novivinyo, ngezinga lokuphendula lilonke lama-96% kanye nezinga lokuphendula eliphelele lama-74.3% elibonwe ezigulini ezibhalisiwe eziyi-103. Le bhulogi ingena ijula ​​kwisayensi engemuva kwe-FUCASO, umthelela wayo ongaba khona ezigulini ze-myeloma, kanye nethemba elilethayo empini yomhlaba wonke yokulwa nalesi sifo esiyinselele.

Li C, Wang D, Song Y, et al.
I-Innovent ne-IASO Bio

"Ngizizwa ngihloniphekile ngokuba yingxenye yeCancerFax, inhlangano enozwelo nezinikele eyenza umehluko ngempela ezimpilweni zeziguli ezinomdlavuza. Ukuzinikela ekunakekelweni kweziguli nokwesekwa lapha akunakuqhathaniswa. Ngiyaziqhenya ngokusebenzisana neqembu elinakekelayo nelinekhono elinjalo. iqembu, futhi ngibheke ngabomvu ukuqhubeka nomsebenzi wethu wokunikeza induduzo nethemba kulabo abalwa nomdlavuza. "

Albert Chen
I-Country Lead - i-China ne-Hong Kong

ICancerFax: Ukunika Izimpilo Amandla, Ukuguqula Uhambo

Our umbono wukuhola indlela yokuguqula indlela yokwelashwa komdlavuza, kuqinisekiswe ukuthi wonke umuntu uyafinyelela ekunakekelweni komuntu siqu, okuphelele, nozwela. Ngezixazululo ezintsha nokuzinikela okungantengantengi, silwela ukuqeda izithiyo, sinikeze ithemba, futhi sibe neqhaza emhlabeni lapho umdlavuza ungelapheki nje kuphela kodwa unqotshwa.

 

Mission Statement

"Ngezixazululo ezintsha nokuzinikela okungantengantengi, silwela ukuqeda izithiyo, sinikeze ithemba, futhi sibe neqhaza emhlabeni lapho umdlavuza ungelapheki nje kodwa unqotshwa."

 

Sizibophezele:

 

  1. Izindlela eziqondene nawe: Ukuhlanganisa izindlela zokwelapha ezihambisana nezidingo ezihlukile zesiguli ngasinye.
  2. I-Global Network: Ukwakha inethiwekhi yomhlaba wonke yama-oncologists aziwayo, izikhungo zokwelapha ezisezingeni eliphezulu, kanye nezinsizakalo ezisekelayo.
  3. Ukunikeza Amandla Ngolwazi: Ukunikeza ulwazi oluphelele, olusesikhathini samanje.
  4. Ukusekela Okunozwelo: Ukunikeza ukusekela okungokomzwelo nokungokoqobo.
  5. Ukuqamba Nokucwaninga: Ukusebenzisana nezikhungo zocwaningo ezihamba phambili.
  6. Ukumela Nokuqwashisa: Ukukhuthaza izinqubomgomo zokunakekelwa komdlavuza ezithuthukisiwe.
  7. Ubuhle Bokuziphatha: Ukugcina izindinganiso zokuziphatha eziphakeme kakhulu.

Hlola imininingwane siwenza kanjani umthelela.

Bathini odokotela ngathi?

“Ngifuna ukudlulisa ukwazisa kwami ​​okusuka enhliziyweni ngezinkonzo ezibalulekile ezinikezwa yi ICancerFax ezigulini zethu ezinomdlavuza. Njengodokotela, ngihlabeke umxhwele ngokujulile ngokuzinikela, ubungcweti, nobungcweti obuvezwe ithimba lakho. Inkampani yakho idlala indima ebalulekile ekuxhumaniseni iziguli zethu nezivivinyo zomtholampilo ezibalulekile kanye nokwelashwa okuseqophelweni eliphezulu, ethuthukisa amathuba azo okululama. Ukuzinikela kwenu ekunakekelweni komuntu siqu kanye nokwesekwa okungantengantengi akuzuzisanga iziguli zethu kuphela kodwa futhi kube negalelo elikhulu ekuthuthukiseni ucwaningo lomdlavuza. Ngiyaziqhenya ngokusebenzisana neCancerFax, njengoba niqhubeka nokuba yisibani sethemba kulabo ababhekene nalolu hambo oluyinselelo.”

 

 

UDkt Jonathan Goldman

I-Medical Oncologist - UCLA Cancer Center, California, USA

Imibuzo ejwayelekile ukubuzwa.

Thola izimpendulo ezingezansi zemibuzo evame kakhulu yeziguli.

Ukubonisana nomdlavuza ku-inthanethi kubhekisela enqubweni yokuthola izeluleko zezokwelapha, ukuxilongwa, kanye nezincomo zokwelashwa ezindabeni eziphathelene nomdlavuza ngokusebenzisa izinkundla ezibonakalayo. Ivumela iziguli ukuthi zixhumane zikude nodokotela be-oncologists nabanye ochwepheshe bezokunakekelwa kwempilo ngezingcingo zevidiyo nobuchwepheshe be-telemedicine. Ukubonisana nge-inthanethi kunikeza lula nokufinyeleleka, ikakhulukazi kulabo abanezinkinga zokuhamba noma abahlala ezindaweni ezikude.

Kusetshenziswa ubuchwepheshe be-telemedicine, ukubonisana nomdlavuza ku-inthanethi kuxhuma iziguli kanye nabasebenzi bezempilo ukude. Iziguli zingaxoxa ngokukhathazeka kwazo okuhlobene nomdlavuza, zabelane ngamarekhodi ezokwelapha, futhi zithole izeluleko zochwepheshe ngamakholi wevidiyo avikelekile noma izinkundla zokuxhumana ngocingo. Odokotela bangahlola ulwazi olunikeziwe bekude futhi banikeze ukuxilongwa, izincomo zokwelashwa, nokusekelwa okuqhubekayo. Uma kudingeka, ochwepheshe bangaphinde baxhumane nodokotela bendawo ukuze benze uhlelo lokwelapha olufaneleka kakhulu isiguli.

ICancerFax ixhunywe kwezinye zezibhedlela ezihamba phambili emhlabeni kanye nezase-USA. Hlola uhlu lwethu lwezibhedlela ngenhla bese ukhetha esifanelana nezidingo zakho. Ithimba lethu lezokwelapha lingakusiza futhi ukuthi ukhethe leyo ehambisana nezidingo zakho nezidingo zakho. Bheka uhlu lwe- izibhedlela ezihamba phambili zomdlavuza e-USA.

Udinga ukuhlinzeka ngamarekhodi ezempilo alandelayo:

  1. Isifinyezo sezokwelapha
  2. Iskena se-PET CT sakamuva
  3. Imibiko yakamuva yegazi
  4. Umbiko we-Biopsy
  5. I-Bone marrow biopsy (Okweziguli ezinomdlavuza wegazi)
  6. Zonke izikena ngefomethi ye-DICOM

Ngaphandle kwalokhu kufanele futhi usayine ifomu lemvume yesiguli elinikezwe yiCancerFax.

Yebo, uthola incwadi kadokotela kanye nombiko ophelele/iphrothokholi ngesikhathi sokwelashwa okudingekayo.

Awudingi noma yimiphi imishini yokubonisana nge-inthanethi; udinga nje ukubonisana nge-pathology kanye nombiko obhaliwe. Ukuze uthole ukubonisana ngevidiyo nocingo, uzodinga ifoni ehlakaniphile enejubane elihle le-inthanethi.

I-CAR T-cell therapy, noma i-chimeric antigen receptor T-cell therapy, iyindlela emisha yokwelashwa kwe-immunotherapy. Kuhilela ukuqoqa ama-T cell esiguli, ukuwaguqula ukuze aqondise amaseli omdlavuza ngempumelelo, bese ebuyisela la maseli ashintshiwe emzimbeni wesiguli. Amaseli e-CAR T angakwazi ukubona futhi ahlasele amaseli omdlavuza ngokunemba. Bheka imininingwane ephelele ku Ukwelashwa kwe-CAR T-Cell.

Ukufaneleka kokwelashwa kwe-CAR T-cell kuncike ezintweni ezihlukahlukene, okuhlanganisa uhlobo lomdlavuza, isigaba sawo, kanye nempilo yesiguli iyonke. Ngokuvamile, ukwelashwa kwe-CAR T-cell kucatshangelwa iziguli ezinezinhlobo ezithile zomdlavuza wegazi obuyele emuva noma ophikisanayo, njenge-leukemia noma i-lymphoma, ezingazange ziphendule ekwelashweni okujwayelekile. I-oncologist yakho izohlola icala lakho elithile ukuze inqume ukufaneleka.

Ukwelashwa kwe-CAR T-cell kungaba nemiphumela engemihle, okuhlanganisa i-cytokine release syndrome (CRS) nemiphumela emibi ye-neurologic. I-CRS ingabangela umkhuhlane, izimpawu ezinjengomkhuhlane, futhi, ezimweni ezimbi kakhulu, ukungasebenzi kwezitho zomzimba. Imiphumela emibi ye-Neurologic ingase ihlanganise ukudideka noma ukuquleka. Ochwepheshe bezokunakekelwa kwempilo baqapha ngokucophelela futhi balawula le miphumela engemihle. Kubalulekile ukuxoxa ngezingozi nezinzuzo ezingaba khona nethimba lakho lezokwelapha.

Ukuhlolwa komtholampilo wucwaningo locwaningo oluklanyelwe ukuhlola izindlela zokwelapha ezintsha noma ukungenelela komdlavuza. Ngokubamba iqhaza, ungase uthole ukufinyelela kumithi yokwelapha esezingeni eliphezulu okungenzeka isebenze kangcono kunokwelashwa okujwayelekile. Izivivinyo zemitholampilo nazo zinomthelela ekuthuthukiseni ulwazi lwezokwelapha kanye nokwenza ngcono ukunakekelwa komdlavuza esikhathini esizayo.

Ungaqala ngokuxoxa ngezinketho zesilingo somtholampilo nodokotela wakho we-oncologist noma umhlinzeki wezempilo. Bangancoma izivivinyo ngokusekelwe ohlotsheni lwakho oluthile lomdlavuza, isigaba, nomlando wezokwelapha. Ngaphezu kwalokho, amawebhusayithi afana I-ClinicalTrials.gov kanye nezinhlangano ezimela isiguli zivame ukuhlinzeka ngemininingwane egciniwe yocwaningo oluqhubekayo.

Izinzuzo zingase zihlanganise ukufinyelela ekwelashweni okusha, ukuqapha okuseduze kwezokwelapha, kanye nemiphumela engase ibe ngcono. Izingozi zingahluka kodwa zingabandakanya imiphumela engemihle evela ekwelashweni kokuhlola noma ithuba lokuthi ukwelashwa okusha kungasebenzi kanye nokunakekelwa okujwayelekile. Kubalulekile ukuxoxisana ngokugcwele kokubili izingozi nezinzuzo nethimba lakho lezempilo ngaphambi kokwenza isinqumo.

Akuzona zonke izivivinyo zomtholampilo ezisebenzisa ama-placebo, futhi eziningi zibandakanya ukuqhathanisa ukwelashwa kokuhlola nezinga lamanje lokunakekela. Uma kusetshenziswa i-placebo, ababambiqhaza baziswe kusengaphambili, futhi imihlahlandlela yokuziphatha iqinisekisa ukuthi akekho owenqatshelwe ukwelashwa okudingekayo. Ithimba lakho lezokunakekelwa kwempilo lizochaza idizayini yesilingo kanye nokuthi i-placebo iyabandakanyeka yini.

Izivivinyo zemitholampilo zenziwa ngokugcizelela kakhulu ukuphepha kwesiguli. Amakomiti okuziphatha nezinhlangano ezilawulayo ziwaqapha eduze futhi aphoqelele izimiso eziyisisekelo. Uzokwaziswa ngezingozi ezingaba khona futhi uqashwe kulo lonke ucwaningo. Ungahoxa esivivinyweni nganoma yisiphi isikhathi uma unokukhathazeka mayelana nokuphepha noma ezinye izinkinga.

Ngokuvamile, umxhasi wesilingo somtholampilo unesibopho sokumboza izindleko zokwelashwa kokuhlola kanye nokuhlola okuhlobene nocwaningo. Kodwa-ke, ungase ube nesibopho sezindleko zokwelashwa ezijwayelekile ezingahlobene nokuhlola, njengokuvakashela odokotela okuvamile noma ukwelapha okungekhona okokuhlola. Kubalulekile ukuxoxa ngezici zezezimali nomxhumanisi wesilingo kanye nomhlinzeki wakho womshwalense ukuze uqonde ukuthi yini ekhavayo kanye nanoma yiziphi izindleko ezingaba khona eziphuma ephaketheni. Izinhlelo eziningi zomshwalense manje zimboza izindleko ezijwayelekile zokubamba iqhaza kocwaningo lomtholampilo.

Ukwelashwa kwe-CAR T-cell kuvamise ukuba ukwelashwa kwesikhathi esisodwa. Kodwa-ke, ezinye iziguli zingase zidinge ukuthakwa okwengeziwe noma ezinye izindlela zokwelapha uma umdlavuza wazo ubuyela emuva noma uma kunesidingo sokunakekelwa kokulandelela isikhathi eside. Uhlelo lwakho lokwelapha luzofanelana nesimo sakho esithile.

Ngemuva kokwelashwa kwe-CAR T-cell, uzogadwa eduze ukuze uthole imiphumela engemihle engaba khona kanye nokuhlola ukusebenza kokwelashwa. Amazinga empumelelo angahluka kuye ngohlobo nesigaba somdlavuza. Ukwelashwa kwe-CAR T-cell kubonise imiphumela ethembisayo kwezinye iziguli ezinomdlavuza wegazi obuye wabuyela emuva noma ongashintshi, okuholela ekukhululweni okuphelele. Nokho, izimpendulo ngazinye zingahluka, futhi kubalulekile ukuxoxa ngesifo sakho nethimba lakho lezokwelapha.

Yebo, ezinye izinkampani seziqalile Ukwelashwa kwe-CAR T-Cell eNdiya ngosizo lwama-vector avela e-China naseMalaysia. Nokho, lokhu kwelashwa kusengaphansi kokuhlolwa komtholampilo. Amafomu emvume yesiguli kanye nezeluleko zikadokotela ziyacelwa ngaphambi kokuthi uye kulezi zivivinyo.

Izindleko zokwelashwa kwe-CAR T-cell ziyahlukahluka kuye ngamazwe. Nazi izindleko ezilinganiselwe emazweni ahlukene.

I-USA- $ 600,000-700,000 USD

I-China - $ 60,000-90,000 USD

I-India - $ 60,000-90,000 USD

I-Israel - $ 85,000-100,000 USD

I-Singapore - $ 700,000-750,000 SGD

 

E-China, ukwelashwa kwe-CAR T-cell kuvunyelwe ngokuyinhloko futhi kusetshenziselwe ukwelapha izifo ze-hematological, njenge-lymphoma, i-leukemia, ne-myeloma.
Yize kukhona ezinye izivivinyo zemitholampilo nemizamo yocwaningo ehlola ukwelashwa kwe-CAR T-cell yamathumba aqinile, inqubekelaphambili kule ndawo ihambe kancane uma iqhathaniswa ne-hematological malignancies.

Ngokolwazi olutholakalayo, izindlela zokwelapha ze-CAR T-cell zamathumba aqinile zenza u-9% kuphela wengqikithi yokwelashwa kwe-CAR T-cell eyenziwa eChina.

Ukusebenza kokwelashwa kwe-chimeric antigen receptor T-cell (CAR-T) e-China kuqhathaniswe nezinye izindlela zokwelapha ngokuhlolwa okubanzi kwemitholampilo nocwaningo. Kusukela ngo-2022, i-China inenani elikhulu lezifundo zomtholampilo ze-CAR-T kune-United States, ikakhulukazi ezifweni ze-hematological. Izindlela zokwelapha ezimbili ze-CAR-T, i-axicabtagene ciloleucel (Yescarta) kanye ne-relmacabtagene autoleucel (Carteyva), zigunyazwe e-China yi-National Medical Products Administration (NMPA).

Ukwelashwa kwe-CAR-T e-China kubonise ukusebenza ngempumelelo ezinkingeni ezihlukahlukene ze-hematological, okuhlanganisa i-B-cell acute lymphoblastic leukemia (ALL), i-lymphoma, ne-multiple myeloma (MM). Nokho, izinselele zisekhona, njengezindleko eziphezulu, inqubo yokukhiqiza edla isikhathi, kanye nezenzakalo ezimbi ezihlobene nokuzivikela komzimba. Ukuze kubhekwane nalezi zinkinga, abacwaningi baseShayina bakha amasu okuthuthukisa ukwelashwa kwe-CAR-T, okuhlanganisa ukuthuthukiswa kwemikhiqizo ye-allogeneic CAR-T kanye nokusetshenziswa kwezinye izizinda ze-costimulatory.

Kafushane, ukwelashwa kwe-CAR-T e-China kubonise imiphumela ethembisayo ku-hematological malignancies, ngenani elikhulu lezivivinyo zomtholampilo uma kuqhathaniswa ne-United States. Kodwa-ke, izinselelo zisekhona, futhi ucwaningo olwengeziwe luyadingeka ukuze kwandiswe ukwelashwa futhi andise ukusetshenziswa kwakho kube izimila eziqinile.

Ukuthengwa kwezitolo okudayisa yonke impahla kwe-CAR-T cell therapy e-China kuvamise ukuzungeze i-Chinese Yuan (CNY) 1,200,000, elingana no-US$170,000. Ukuphumelela kwezindleko zokwelashwa kwamaseli e-CAR-T e-China kuyahlukahluka kuye ngokwelashwa okuqondile kanye nesimo sesiguli. Isibonelo, isilinganiso esikhulayo sokusebenza ngempumelelo kwezindleko (ICER) se-Axicabtagene ciloleucel (Axi-cel) ngokumelene nezinga lokunakekelwa (SOC) ezigulini ezine-B-cell lymphoma (DLBCL) esabalele enkulu kumugqa wesibili (2L) cishe I-CNY 363,977 ngonyaka wokuphila olungiswe ngekhwalithi (QALY). Kodwa-ke, lezi zindlela zokwelapha azibhekwa njengezingabizi kakhulu kunoma yiziphi izilungiselelo ze-DLBCL ezigulini ze-DLBCL ku-World Health Organization (WHO) -umkhawulo onconywayo wokuzimisela ukukhokha. Ukwehliswa kwentengo yokwelashwa kwe-CAR-T kuyindlela eyinhloko yokwehlisa ama-ICER nokuqinisekisa ukuthi izindleko zomuthi zilingana nezinzuzo zezempilo zesiguli.

Izibhedlela Eziphezulu Zomdlavuza

Top Ama-Oncologists

Isithombe sesimeli esijwayelekile
UDkt. Erica L. Mayer

Boston, United States

Umqondisi, Ucwaningo Lomtholampilo , Isipiliyoni: 23
Isithombe sesimeli esijwayelekile
UDkt Ang Peng Tiam

Singapore

Umqondisi Wezokwelapha kanye Nomeluleki Omkhulu Wezokwelapha I-Oncology , Isipiliyoni: Iminyaka engama-24
Isithombe sesimeli esijwayelekile
UProfesa Peihua Peggy Lu

Beijing, eChina

Umongameli Omkhulu Wezokwelapha wesibhedlela i-Lu Daopei, e-Beijing, e-China , Isipiliyoni: Iminyaka engama-27
Isithombe sesimeli esijwayelekile
UProfesa Arnon Nagler

I-Tel Aviv, i-Israel

Umqondisi Wophiko Lwe-Hematology , Isipiliyoni: Iminyaka engama-34

Latest kuCancer

Qala ingxoxo
Udinga usizo ngokwelashwa komdlavuza?
Skena ikhodi
Sawubona,
Siyakwamukela kuCancerFax!

ICancerFax ingumsizi wesiguli othembekile emhlabeni wonke osebenza nezibhedlela eziphezulu zomdlavuza emhlabeni ezifana no-MD Anderson, Dana Farber, Asan, NCC Japan, Sheba, Beijing Cancer Institute kanye ne-Apollo ukukulethela okungcono kakhulu kwezokwelapha nezidakamizwa.

Sazise ukuthi yimaphi amasevisi ongathanda ukuwasebenzisa?

1) Ukwelashwa komdlavuza e-USA, Japan, Israel, India, Korea noma Singapore?
2) Ukwelashwa kwe-CAR T-Cell therapy
3) Umuthi wokugomela umdlavuza
4) Ukubonisana ngevidiyo eku-inthanethi
5) Ukwelashwa kweProton